Skip to main content

Table 1 Clinical and demographic data of PsA patients (n=30) at time of arthroscopy*

From: Cytokine expression in synovial tissue of psoriatic arthritis and its relationship with lymphoid neogenesis, disease activity and erosive disease: a longitudinal study

Age (years) at time of arthroscopy

47

(37;60)

Disease duration before arthroscopy (months)

110

(30;170)

Time of follow-up after arthroscopy (months)

35

(22;45)

Tender Joint Count

2

(1;2)

Swollen Joint Count

2

(1;3)

CRP (mg/dL)

1.77

(0.30; 5.51)

ESR (mm/1st hour)

18.5

(8;52)

ACPA (Ul/mIL) (n, positive > 25)

0

 

Rheumatoid Factor (Ul/ml) (n, positive>20)

2

 

DAS28 3v

3.63

(2.73; 4.59)

Joint Pattern

  

   Polyarthritis; n (%)

11

36.7

   Oligoarthritis, n (%)

19

63.3

Type of Psoriasis

  

Type I (<40 years), n (%)

22

70.3

Type II (>40 years), n (%)

8

29.7

  1. *Data are expressed as median and IQR. CRP: C-reative protein; ESR: erythrocyte sedimentation rate; ACPA: anti-citrullinated peptide/protein antibodies; DAS: disease activity score